Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder of infants in which there is progressive obliteration or discontinuity of the extrahepatic biliary system, resulting in obstruction of bile flow.
Features include: Increased total bilirubin, Extrahepatic biliary duct atresia, Enlarged liver (hepatomegaly), and Liver scarring (cirrhosis) (cirrhosis) and 8 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 5 | Extrahepatic biliary duct atresia, Enlarged liver (hepatomegaly), Liver scarring (cirrhosis) (cirrhosis) |
Biomarker and diagnostic research for extrahepatic biliary atresia has been reported in the published literature.
No clinical trials have been registered for extrahepatic biliary atresia.
21 publications have been identified in PubMed for extrahepatic biliary atresia. Research spans Case Report / Case Series (62%), Basic Science / Preclinical (14%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 62% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lab test results
3 |
High bilirubin levels (unconjugated hyperbilirubinemia), Hyperbilirubinemia, Elevated circulating hepatic transaminase concentration |
3 |
14% |
Research summaries | 2 | 10% |
Disease patterns and progression | 2 | 10% |
Testing and diagnosis research | 1 | 5% |
Khan M (2026). [PMID: 42256702](https://pubmed.ncbi.nlm.nih.gov/42256702/). *Clin Med Insights Case Rep*. [Case Report / Case Series]
Jose JN (2026). [PMID: 41874938](https://pubmed.ncbi.nlm.nih.gov/41874938/). *Indian Pediatr*. [Epidemiology / Natural History]
Thong PL (2026). [PMID: 42016698](https://pubmed.ncbi.nlm.nih.gov/42016698/). *Clin Case Rep*. [Case Report / Case Series]
Har-Zahav A (2026). [PMID: 42183052](https://pubmed.ncbi.nlm.nih.gov/42183052/). *Front Bioeng Biotechnol*. [Basic Science / Preclinical]
Pal A (2026). [PMID: 42144297](https://pubmed.ncbi.nlm.nih.gov/42144297/). *Transplant Proc*. [Case Report / Case Series]
El-Shabrawi MHF (2025). [PMID: 39922799](https://pubmed.ncbi.nlm.nih.gov/39922799/). *J Int Med Res*. [Case Report / Case Series]
Zhang L (2025). [PMID: 41488348](https://pubmed.ncbi.nlm.nih.gov/41488348/). *iScience*. [Basic Science / Preclinical]
Feyang Limbu D (2025). [PMID: 40979434](https://pubmed.ncbi.nlm.nih.gov/40979434/). *J Surg Case Rep*. [Case Report / Case Series]
Leal-Leyte P (2025). [PMID: 40275779](https://pubmed.ncbi.nlm.nih.gov/40275779/). *Pediatr Transplant*. [Case Report / Case Series]
Almohammad NH (2025). [PMID: 40335098](https://pubmed.ncbi.nlm.nih.gov/40335098/). *Saudi Med J*. [Epidemiology / Natural History]